Insider Trading & Ownership - Bellerophon Therapeutics Inc. (BLPH)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Bellerophon Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-13
Sale
2023-10-16
8:51 pm
Bellerophon Therapeutics Inc.BLPHPuissance Capital Management LP
Puissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Wang Theodore T
10% Owner
1,076,841$0.1038$111,7760
(Direct)
View
2023-06-07
Sale
2023-06-07
9:21 pm
Bellerophon Therapeutics Inc.BLPHPuissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Wang Theodore T
10% Owner
134,421$0.83$111,5691,076,841
(Direct)
View
2023-05-18
Sale
2023-05-22
6:51 pm
Bellerophon Therapeutics Inc.BLPHKim Bobae
VP Reg. Affairs & Quality
9,455$10$94,5501,867
(Direct)
View
2023-05-18
Sale
2023-05-19
8:55 pm
Bellerophon Therapeutics Inc.BLPHPuissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Wang Theodore T
Puissance Capital Management LP
10% Owner
560,000$9.46$5,297,6001,211,262
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-07
Option Award
2023-06-09
4:12 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHAmin Naseem
Director
47,578$0291,865
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:12 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHFernandes Peter
See Remarks
100,000$0100,000
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:11 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHShah Parag Suresh
VP of Business Operations
50,000$050,000
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:11 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHDekker Martin
See Remarks
50,000$050,000
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:11 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHBruder Scott P
Director
14,607$014,607
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:10 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHKim Bobae
VP Reg. Affairs & Quality
50,000$050,000
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:10 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHWang Theodore T
Director
14,607$014,607
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:10 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHCloyd Mary Ann
Director
14,607$014,607
(Direct)
View
2023-06-07
Option Award
2023-06-09
4:10 pm
N/A
2033-06-07
Bellerophon Therapeutics Inc.BLPHTeufel Crispin
Director
14,607$014,607
(Direct)
View
2023-05-18
Exercise
2023-05-22
6:51 pm
N/A
2026-12-07
Bellerophon Therapeutics Inc.BLPHKim Bobae
VP Reg. Affairs & Quality
1,288$01,867
(Direct)
View
2023-05-18
Exercise
2023-05-22
6:51 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHKim Bobae
VP Reg. Affairs & Quality
266$7.351,867
(Direct)
View
2023-05-18
Exercise
2023-05-22
6:51 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHKim Bobae
VP Reg. Affairs & Quality
1,022$7.51,867
(Direct)
View

Ownership
2023-04-03
5:46 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHKim Bobae
VP Reg. Affairs & Quality
0$074,655
(Direct)
View
2023-02-10
Option Award
2023-02-14
7:32 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHAmin Naseem
Director
84,000$0244,287
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:48 pm
2024-02-10
2033-02-10
Bellerophon Therapeutics Inc.BLPHTeufel Crispin
Director
29,000$1.5229,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:47 pm
N/A
2033-02-10
Bellerophon Therapeutics Inc.BLPHDekker Martin
VP OF ENGINEERING & MANUFACTUR
50,000$1.5250,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:47 pm
N/A
2033-02-10
Bellerophon Therapeutics Inc.BLPHShah Parag Suresh
VP OF BUSINESS OPERATIONS
50,000$1.5250,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:46 pm
N/A
2033-02-10
Bellerophon Therapeutics Inc.BLPHFernandes Peter
CHIEF EXECUTIVE OFFICER
100,000$1.52100,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:46 pm
N/A
2033-02-10
Bellerophon Therapeutics Inc.BLPHLaccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)
50,000$1.5250,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:45 pm
2024-02-10
2033-02-10
Bellerophon Therapeutics Inc.BLPHWang Theodore T
Director
10% Owner
29,000$1.5229,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:45 pm
2024-02-10
2033-02-10
Bellerophon Therapeutics Inc.BLPHCloyd Mary Ann
Director
29,000$1.5229,000
(Direct)
View
2023-02-10
Option Award
2023-02-14
4:45 pm
2024-02-10
2033-02-10
Bellerophon Therapeutics Inc.BLPHBruder Scott P
Director
29,000$1.5229,000
(Direct)
View
2022-12-09
Exercise
2022-12-13
5:26 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHDekker Martin
VP OF ENGINEERING & MANUFACTUR
25,500$043,166
(Direct)
View
2022-12-09
Tax Withholding
2022-12-13
5:26 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHDekker Martin
VP OF ENGINEERING & MANUFACTUR
7,834$0.930143,166
(Direct)
View
2022-12-09
Exercise
2022-12-13
5:25 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHShah Parag Suresh
VP OF BUSINESS OPERATIONS
25,500$043,166
(Direct)
View
2022-12-09
Tax Withholding
2022-12-13
5:25 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHShah Parag Suresh
VP OF BUSINESS OPERATIONS
7,834$0.930143,166
(Direct)
View
2022-12-09
Exercise
2022-12-13
5:25 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHLaccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)
18,000$030,470
(Direct)
View
2022-12-09
Tax Withholding
2022-12-13
5:25 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHLaccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)
5,530$0.930130,470
(Direct)
View
2022-12-09
Exercise
2022-12-13
5:25 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHFernandes Peter
PRINCIPAL EXECUTIVE OFFICER
32,500$055,015
(Direct)
View
2022-12-09
Tax Withholding
2022-12-13
5:25 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHFernandes Peter
PRINCIPAL EXECUTIVE OFFICER
9,985$0.930155,015
(Direct)
View
2022-01-26
Option Award
2022-01-28
4:31 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHFernandes Peter
CHIEF REGULATORY & SAFETY OFFR
65,000$065,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
4:31 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHDekker Martin
VP OF ENGINEERING & MANUFACTUR
51,000$051,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
4:30 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHShah Parag Suresh
VP OF BUSINESS OPERATIONS
51,000$051,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
4:30 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHLaccona Nicholas
FINANCIAL OFFICER, (PFO & PAO)
36,000$036,000
(Direct)
View
2021-12-31
Option Award
2022-01-04
4:10 pm
2022-12-31
2031-12-31
Bellerophon Therapeutics Inc.BLPHCloyd Mary Ann
Director
21,828$3.136,300
(Direct)
View
2021-12-31
Option Award
2022-01-04
4:10 pm
2022-12-31
2031-12-31
Bellerophon Therapeutics Inc.BLPHWang Theodore T
Director
10% Owner
21,828$3.135,634
(Direct)
View
2021-12-31
Option Award
2022-01-04
4:10 pm
2022-12-31
2031-12-31
Bellerophon Therapeutics Inc.BLPHTeufel Crispin
Director
21,828$3.133,087
(Direct)
View
2021-12-31
Option Award
2022-01-04
4:10 pm
2022-12-31
2031-12-31
Bellerophon Therapeutics Inc.BLPHBruder Scott P
Director
21,828$3.136,966
(Direct)
View
2021-12-31
Option Award
2022-01-04
4:10 pm
2022-12-31
2031-12-31
Bellerophon Therapeutics Inc.BLPHAmin Naseem
Director
8,671$3.1184,096
(Direct)
View
2021-12-31
Option Award
2022-01-04
4:10 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHAmin Naseem
Director
39,032$0184,096
(Direct)
View

Ownership
2021-10-08
5:26 pm
N/A
2030-09-10
Bellerophon Therapeutics Inc.BLPHLaccona Nicholas
Controller, (PFO & PAO)
0$01,500
(Direct)
View
2021-06-07
Option Award
2021-06-08
12:37 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHPuissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner
8,189$41,771,262
(Direct)
View
2021-04-26
Option Award
2021-04-26
12:39 pm
2016-11-29
2023-11-29
Bellerophon Therapeutics Inc.BLPHPuissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner
685,236$02,829,263
(Direct)
View
2021-04-26
Option Award
2021-04-26
12:39 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHPuissance Life Science Opportunities Fund VI
Puissance Capital Fund (GP) LLC
Puissance Capital Management LP
Puissance Capital Management (GP) LLC
Wang Theodore T
10% Owner
609,231$42,829,263
(Direct)
View
2021-03-31
Option Award
2021-04-02
4:10 pm
N/A
N/A
Bellerophon Therapeutics Inc.BLPHPeacock Jonathan M
Director
15,308$0157,033
(Direct)
View
Goto 0, 1, Next